UNASSIGNED: The incidence of @entity6923 (BSI) has increased during the past decades. Species distribution is changing worldwide, and non-albicans Candida spp. are becoming more prevalent. Acquired resistance to antifungal agents has been documented in several reports. The aim of our study was to assess the epidemiology and antifungal susceptibility of Candida isolates from BSI at our institute. The incidence of Candida BSI increased during the first four years of our investigation, from 1.7 to 3.5 episodes / 10 000 admissions, then dropped to 2.66 episodes / 10 000 admissions in the last year. The most frequently isolated species was @entity5132 (63%), followed by @entity7408 (13%), @entity7409 (10.2%), @entity9841 (9.3%), and C. krusei (3.7%). One isolate each of C. kefyr, C. fabianii and C. inconspicua were detected. The percentage of @entity5132 remained stable throughout the study period. The most frequent risk factors of Candida BSI in our @entity1 population were intensive care treatment (60.4%), abdominal surgery (52.5%), and solid @entity5 (30.7%). All isolates were wild-type organisms, no acquired antifungal resistance was detected.

Significance of yeasts in bloodstream infection: Epidemiology and predisposing factors of Candidaemia in adult XXXX at a university hospital (2010-2014).

@entity9841 :: ('5482', 'Species') :: ['C. tropicalis'] @entity1 :: ('9606', 'Species') :: ['patient'] @entity6923 :: ('MESH:C536777', 'Disease') :: ['Candida bloodstream infection'] @entity7408 :: ('5478', 'Species') :: ['C. glabrata'] @entity5 :: ('MESH:D009369', 'Disease') :: ['malignancy'] @entity7409 :: ('5480', 'Species') :: ['C. parapsilosis'] @entity5132 :: ('5476', 'Species') :: ['C. albicans']
@entity1 :: (9606,Species) :: ['patients']
